Trade

NGL Fine Chem Ltd share price

High risk
  • 62%Low risk
  • 62%Moderate risk
  • 62%Balanced risk
  • 62%High risk
  • 62%Extreme risk
  • 2,211.00(-1.95%)
    April 17, 2026 15:29:47 PM IST
    • NSE
    • BSE
  • Vol : 7.55 K (NSE + BSE)
    Last 20 day avg : 7.33 K

NGL Fine Chem Ltd is trading -1.95% lower at Rs 2,211.00 as compared to its last closing price. NGL Fine Chem Ltd has been trading in the price range of 2,302.90 & 2,201.00. NGL Fine Chem Ltd has given 59.81% in this year & -3.61% in the last 5 days. NGL Fine Chem Ltd has TTM P/E ratio 24.56 as compared to the sector P/E of 24.14.The company posted a net profit of 15.69 Crores in its last quarter.Listed peers of NGL Fine Chem Ltd include Sun Pharmaceutical Industries (-1.06%), Divi's Laboratories (-1.06%), Torrent Pharmaceuticals (0.78%).The Mutual Fund holding in NGL Fine Chem Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in NGL Fine Chem Ltd was at 0.05% in 31 Dec 2024. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 18, 2026, 11:40 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.18
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.27
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.08
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    4.92
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    39.25
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -1.58
    Indicates undervaluation
Price range
Day Range
Lowest
2,201.00
Highest
2,302.90
52 week range
Lowest
985.05
Highest
2,596.00
NGL Fine Chem Ltd Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,675.20-1.064,01,927.1334.535.51.000.50
Divi's Laboratories
Neutral
6,230.60-1.061,65,415.9974.0110.850.490.01
Torrent Pharmaceuticals
Bullish
4,188.950.781,41,699.2272.9618.530.8417.62
Lupin
Bullish
2,321.40-0.221,06,303.1931.886.190.5111.80
Dr Reddy's Laboratories
Moderately Bearish
1,239.001.451,03,409.1618.133.060.652.34
Mutual Fund Ownership
View all
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.01
  • % of AUM 0.01
NGL Fine Chem Ltd Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-03Quarterly Results
2025-11-12Quarterly Results
2025-08-01Quarterly Results
2025-05-22Audited Results & Final Dividend
2025-02-07Quarterly Results
About the company NGL Fine Chem Ltd
  • IndustryBiotechnology & Drugs
  • ISININE887E01022
  • BSE Code524774
  • NSE CodeNGLFINE
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
  • Management Info
  • Rajesh LawandeChief Financial Officer, Whole Time Director
  • Rahul NachaneManaging Director, Executive Director
NGL Fine Chem Ltd Share Price FAQs

NGL Fine Chem Ltd is trading at 2211.00 as on Fri Apr 17 2026 09:59:47. This is -1.95% lower as compared to its previous closing price of 2255.05.

The market capitalization of NGL Fine Chem Ltd is 1367.00 Cr as on Fri Apr 17 2026 09:59:47.

The 52 wk high for NGL Fine Chem Ltd is 2596.00 whereas the 52 wk low is 985.05

NGL Fine Chem Ltd can be analyzed on the following key metrics -

  • TTM P/E: 24.56
  • Sector P/E: 24.14
  • Dividend Yield: 0.08%
  • D/E ratio: -

NGL Fine Chem Ltd reported a net profit of 21.12 Cr in 2025.